Frederick J. Lynch - Mar 21, 2022 Form 4 Insider Report for H-CYTE, INC. (HCYT)

Role
10%+ Owner
Signature
/s/ Frederick J. Lynch
Stock symbol
HCYT
Transactions as of
Mar 21, 2022
Transactions value $
$233,010
Form type
4
Date filed
3/23/2022, 08:00 AM
Previous filing
Feb 17, 2022
Next filing
May 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCYT COMMON STOCK Exercise of in-the-money or at-the-money derivative security $117K +8.32M $0.01 8.32M Mar 21, 2022 (SEE FOOTNOTE) F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCYT STOCK PURCHASE WARRANTS Exercise of in-the-money or at-the-money derivative security -8.32M -31.75% 17.9M Mar 21, 2022 COMMON STOCK 8.32M $0.01 (SEE FOOTNOTE) F1, F2
transaction HCYT STOCK PURCHASE WARRANTS Other $117K +8.32M $0.01 8.32M Mar 21, 2022 COMMON STOCK 8.32M $0.01 (SEE FOOTNOTE) F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Securities held of record by CFRS Investments, LLC, of which Frederick J. Lynch is the sole manager. Each reporting person disclaims beneficial ownership of the securities except to the extent of its or his pecuniary interest therein.
F2 Received in connection with variable conversion price notes. No additional consideration was paid for warrants. Exercise price became fixed at closing of Qualified Financing.
F3 Represents five-year inducement warrants received from the issuer in connection with the exercise of the ten-year warrants.